Corporate Banner
Satellite Banner
Technology Networks Header
Friday, August 22, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Metabolon Launches Fourth Generation DiscoveryHD4™ Metabolomics Platform
Saturday, April 05, 2014
New technology advancements have potential to lead the way to new scientific breakthroughs, novel biomarkers and discoveries, and support diagnostic product pipeline.

Waters Progenesis QI Marks Next Generation of LC-MS 'Omics Analysis
Friday, April 04, 2014
Company unveiled two new data analysis software packages for proteomics and metabolomics/lipidomics analyses: Progenesis® QI and Progenesis QI for Proteomics at Analytica.

Cancer Genetics Expands BioDiscovery's Nexus Copy Number Platform
Thursday, April 03, 2014
Expansion to identify novel biomarkers predictive of cancer outcomes.

Identifying Epigenetic Biomarkers for Prostate Cancer
Tuesday, April 01, 2014
IDT qPCR assays and probes facilitate the development of predictive epigenetic biomarkers.

New Open Access Platform Desktop Spotter To Be Unveiled At Analytica in Germany
Thursday, March 27, 2014
Poly-Pico Technologies Ltd. are showcasing their new open access platform desktop ‘Pico Spotter™’ at Analytica Munich in Germany next month.

AbsoluteIDQ® p180 by BIOCRATES Life Sciences AG
Tuesday, March 25, 2014
Cutting-edge test kit made in Austria helps develop the world’s first metabolomics-based blood test to predict Alzheimer’s disease.

Syngene Expands its Range of Imaging Systems
Thursday, March 20, 2014
For fast, accurate imaging of 2D or 1D gels and all blot types.

Molecular Devices to Showcase Next Generation SpectraMax® MiniMax™ 300 Imaging Cytometer at Analytica
Wednesday, March 19, 2014
SpectraMax® MiniMax™ 300 imaging cytometer enables both cellular visualization and first-of-its-kind stain free cell-based analysis on the field-upgradable SpectraMax®i3 Multi-Mode Microplate Reader.

Reinventing Buffer Screening with Avacta’s Optim Technology
Tuesday, March 18, 2014
Optim system screen a wide range of buffer conditions quickly and cheaply.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 1228
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv